FLINT — Hurley Medical Center announced its first use of Evia HF-T triple-chamber cardiac resynchronization therapy (CRT) pacemaker device. The device puts out pulses to keep the heart beating regularly and on time, improving the health of patients with conditions such as bradycardia and heart failure.
A patient had the device implanted at Hurley Medical Center on Oct. 18 by Abdul K. Alaawa, MD, FACC, a Hurley physician board certified in Cardiology, Electrophysiology and Pacing.
According to the American Heart Association, about 5.7 million people suffer from heart failure. There will be 670,000 new cases diagnosed each year, and more than 277,000 people will die of heart failure, according to statistics.
Hurley’s goal is to decrease heart disease in our community using the latest state of the art technology, official said.
“This implant provides physiologic pacing in heart failure, and allows for remote medical monitoring and superior longevity, to support a patient’s quality of life,” said Alaawa.
Evia HF-T is the only CRT pacemaker to offer all of the therapeutic benefits available in competing CRT pacemakers — including allowing for daily cellular home monitoring with no cost to the patient. Evia HF-T offers the company’s revolutionary Closed-Loop Stimulation (CLS) technology, the only rate response algorithm that is FDAapproved to respond to exercise and acute mental stress on a beat-to-beat basis.
Electrophysiologists ranging from private practice to academic training centers agree that BIOTRONIK’s Evia HF-T offers groundbreaking technology, which makes it an ideal option for patients with heart failure conditions.
Increased lung fluid levels can be one indicator of heart failure progression, and BIOTRONIK’s Evia HF-T devices contain the company’s proprietary TI feature, which measures thoracic impedance. The patient’s physician can use this information as additional insight to manage critically important aspects of patient care.